[Kininogenesis in plasma free from fibrinolysis inhibitors]. 1979

R Tymińska-Brzósko, and A Lussa, and K Buluk

UI MeSH Term Description Entries
D007704 Kininogens Endogenous peptides present in most body fluids. Certain enzymes convert them to active KININS which are involved in inflammation, blood clotting, complement reactions, etc. Kininogens belong to the cystatin superfamily. They are cysteine proteinase inhibitors. HIGH-MOLECULAR-WEIGHT KININOGEN; (HMWK); is split by plasma kallikrein to produce BRADYKININ. LOW-MOLECULAR-WEIGHT KININOGEN; (LMWK); is split by tissue kallikrein to produce KALLIDIN. Cystatins, Kininogen,Kininogen,Prekinins,Prokinins,T-Kininogen,Thiostatin,Kininogen Cystatins,T Kininogen
D007705 Kinins A generic term used to describe a group of polypeptides with related chemical structures and pharmacological properties that are widely distributed in nature. These peptides are AUTACOIDS that act locally to produce pain, vasodilatation, increased vascular permeability, and the synthesis of prostaglandins. Thus, they comprise a subset of the large number of mediators that contribute to the inflammatory response. (From Goodman and Gilman's The Pharmacologic Basis of Therapeutics, 8th ed, p588) Kinin
D010949 Plasma The residual portion of BLOOD that is left after removal of BLOOD CELLS by CENTRIFUGATION without prior BLOOD COAGULATION. Blood Plasma,Fresh Frozen Plasma,Blood Plasmas,Fresh Frozen Plasmas,Frozen Plasma, Fresh,Frozen Plasmas, Fresh,Plasma, Blood,Plasma, Fresh Frozen,Plasmas,Plasmas, Blood,Plasmas, Fresh Frozen
D005341 Fibrinolysin A product of the lysis of plasminogen (profibrinolysin) by PLASMINOGEN activators. It is composed of two polypeptide chains, light (B) and heavy (A), with a molecular weight of 75,000. It is the major proteolytic enzyme involved in blood clot retraction or the lysis of fibrin and quickly inactivated by antiplasmins. Plasmin,Fibrogammin,Glu-Plasmin,Protease F,Thrombolysin,Glu Plasmin
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000933 Antifibrinolytic Agents Agents that prevent fibrinolysis or lysis of a blood clot or thrombus. Several endogenous antiplasmins are known. The drugs are used to control massive hemorrhage and in other coagulation disorders. Antifibrinolysin,Antifibrinolysins,Antifibrinolytic,Antifibrinolytic Agent,Antiplasmin,Antiplasmins,Antifibrinolytics,Plasmin Inhibitor,Plasmin Inhibitors,Agent, Antifibrinolytic,Agents, Antifibrinolytic,Inhibitor, Plasmin,Inhibitors, Plasmin

Related Publications

R Tymińska-Brzósko, and A Lussa, and K Buluk
January 1988, Zentralblatt fur Gynakologie,
R Tymińska-Brzósko, and A Lussa, and K Buluk
February 1985, Polskie Archiwum Medycyny Wewnetrznej,
R Tymińska-Brzósko, and A Lussa, and K Buluk
January 1981, Khirurgiia,
R Tymińska-Brzósko, and A Lussa, and K Buluk
May 1983, Biulleten' eksperimental'noi biologii i meditsiny,
R Tymińska-Brzósko, and A Lussa, and K Buluk
January 1986, Anesteziologiia i reanimatologiia,
R Tymińska-Brzósko, and A Lussa, and K Buluk
August 1983, Behring Institute Mitteilungen,
R Tymińska-Brzósko, and A Lussa, and K Buluk
January 1997, Clinical laboratory science : journal of the American Society for Medical Technology,
R Tymińska-Brzósko, and A Lussa, and K Buluk
January 1976, Przeglad lekarski,
R Tymińska-Brzósko, and A Lussa, and K Buluk
July 1981, Pediatria polska,
R Tymińska-Brzósko, and A Lussa, and K Buluk
October 1975, British journal of haematology,
Copied contents to your clipboard!